| You are here: Home: BCU 1|2004: Aron Goldhirsch, MD: Select publications
Select publications
Publications discussed by Dr Goldhirsch
Albain K et al. Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: Initial results from Intergroup trial 0100 (SWOG-8814). Proc ASCO 2002;Abstract 143.
Colleoni M et al. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: Antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 2002;13(1):73-80. Abstract
Davidson NE et al. Chemohormonal therapy in premenopausal, node-positive, receptor-positive breast cancer: An Eastern Cooperative Oncology Group Phase III Intergroup trial (E5188,INT-0101). Proc ASCO 2003;Abstract 15.
Gomez Cuadra MO. 5th Milan Breast Cancer Conference, Milan, Italy, 11-13 June 2003. Breast Cancer Res 2003;5(5):276-9. No abstract available.
Jakesz R et al. Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: Evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer-Austrian Breast and Colorectal Cancer Study Group Trial 5. J Clin Oncol 2002;20(24):4621-7. Abstract
Klijn JG et al. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study. J Natl Cancer Inst 2000;92(11):903-11. Abstract
Waeber M et al. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: Definitive results of a Phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 2003;14(8):1215-21. Abstract
|
